Taiwan FDA registration 4e666af17b1e8a2e53879bd45c108b9a
“Bard” Magnum Reusable Core Biopsy Instrument
TW: “巴德”瑪格寧可重複使用式核心取樣器械
Taiwan·Risk Class 2·MD·BARD PERIPHERAL VASCULAR, INC.·Registered Jun 07, 2017 – Jun 07, 2027ActiveRegistration details
- Analysis ID
- 4e666af17b1e8a2e53879bd45c108b9a
- License Form
- Ministry of Health Medical Device Import No. 029895
- Customs Code
- DHA05602989501
Company information
- Manufacturer
- BARD PERIPHERAL VASCULAR, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology-urology devices
- Product Type (Level 2)
- H1075 Gastroenterology - Urology biopsy instruments
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 07, 2017
- Expiry Date
- Jun 07, 2027
About this record
Access comprehensive regulatory information for “Bard” Magnum Reusable Core Biopsy Instrument in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4e666af17b1e8a2e53879bd45c108b9a and manufactured by BARD PERIPHERAL VASCULAR, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices